Cliona M. Rooney Center for Cell and Gene Therapy Baylor College of Medicine Biography Publications Institution JoVE Articles Cliona M. Rooney has not added a biography. If you are Cliona M. Rooney and would like to personalize this page please email our Author Liaison for assistance. Publications Large-scale Ex Vivo Expansion and Characterization of Natural Killer Cells for Clinical Applications Cytotherapy. Aug, 2012 | Pubmed ID: 22900959 T-cell Therapy in the Treatment of Post-transplant Lymphoproliferative Disease Nature Reviews. Clinical Oncology. Sep, 2012 | Pubmed ID: 22801669 Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections Molecular Therapy : the Journal of the American Society of Gene Therapy. Aug, 2012 | Pubmed ID: 22801446 Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Feb, 2012 | Pubmed ID: 22306904 Replication-competent Retroviruses in Gene-modified T Cells Used in Clinical Trials: is It Time to Revise the Testing Requirements? Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2012 | Pubmed ID: 22297819 Production of Good Manufacturing Practice-grade Cytotoxic T Lymphocytes Specific for Epstein-Barr Virus, Cytomegalovirus and Adenovirus to Prevent or Treat Viral Infections Post-allogeneic Hematopoietic Stem Cell Transplant Cytotherapy. Jan, 2012 | Pubmed ID: 22172091 Adoptive Transfer of Virus-directed T Cells: Will This Fly for Flu? Cytotherapy. Feb, 2012 | Pubmed ID: 22149160 Inducible Apoptosis As a Safety Switch for Adoptive Cell Therapy The New England Journal of Medicine. Nov, 2011 | Pubmed ID: 22047558 Aggressive Peripheral CD70-positive T-cell Lymphoma Associated with Severe Chronic Active EBV Infection Pediatric Blood & Cancer. Oct, 2011 | Pubmed ID: 21994111 Antitumor Activity and Long-term Fate of Chimeric Antigen Receptor-positive T Cells in Patients with Neuroblastoma Blood. Dec, 2011 | Pubmed ID: 21984804 Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2011 | Pubmed ID: 21915103 Improving T-cell Therapy for Relapsed EBV-negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2011 | Pubmed ID: 21908573 Combining MTor Inhibitors with Rapamycin-resistant T Cells: a Two-pronged Approach to Tumor Elimination Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2011 | Pubmed ID: 21878902 PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2011 | Pubmed ID: 21772253 CD28 Costimulation Improves Expansion and Persistence of Chimeric Antigen Receptor-modified T Cells in Lymphoma Patients The Journal of Clinical Investigation. May, 2011 | Pubmed ID: 21540550 Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide Molecular Therapy : the Journal of the American Society of Gene Therapy. Jun, 2011 | Pubmed ID: 21505424 Posttransplant Lymphoproliferative Disease Following Liver Transplantation Current Opinion in Organ Transplantation. Jun, 2011 | Pubmed ID: 21467936 Characterization and Treatment of Chronic Active Epstein-Barr Virus Disease: a 28-year Experience in the United States Blood. Jun, 2011 | Pubmed ID: 21454450 Ex Vivo Gene Transfer for Improved Adoptive Immunotherapy of Cancer Human Molecular Genetics. Apr, 2011 | Pubmed ID: 21415041 Good Manufacturing Practice-grade Cytotoxic T Lymphocytes Specific for Latent Membrane Proteins (LMP)-1 and LMP2 for Patients with Epstein-Barr Virus-associated Lymphoma Cytotherapy. May, 2011 | Pubmed ID: 21361747 High-avidity Cytotoxic T Lymphocytes Specific for a New PRAME-derived Peptide Can Target Leukemic and Leukemic-precursor Cells Blood. Mar, 2011 | Pubmed ID: 21278353 A Th1-inducing Adenoviral Vaccine for Boosting Adoptively Transferred T Cells Molecular Therapy : the Journal of the American Society of Gene Therapy. Jan, 2011 | Pubmed ID: 20959814 Enhancement of Dendritic Cells As Vaccines for Cancer Immunotherapy. Nov, 2010 | Pubmed ID: 21091116 Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients with Locoregional Nasopharyngeal Carcinoma Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2010 | Pubmed ID: 20948438 Immunotherapeutic Options for Epstein-Barr Virus-associated Lymphoproliferative Disease Following Transplantation Immunotherapy. Sep, 2010 | Pubmed ID: 20874650 T Cells Expressing Constitutively Active Akt Resist Multiple Tumor-associated Inhibitory Mechanisms Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2010 | Pubmed ID: 20842106 Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2010 | Pubmed ID: 20842059 IRAK-M Removal Counteracts Dendritic Cell Vaccine Deficits in Migration and Longevity Journal of Immunology (Baltimore, Md. : 1950). Oct, 2010 | Pubmed ID: 20817880 Allogeneic Virus-specific T Cells with HLA Alloreactivity Do Not Produce GVHD in Human Subjects Blood. Nov, 2010 | Pubmed ID: 20709906 Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex) Journal of Immunotherapy (Hagerstown, Md. : 1997). Apr, 2010 | Pubmed ID: 20445351 Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: a 10-year Experience Cytotherapy. Oct, 2010 | Pubmed ID: 20429793 Antigen-specific Cytotoxic T Lymphocytes Can Target Chemoresistant Side-population Tumor Cells in Hodgkin Lymphoma Leukemia & Lymphoma. May, 2010 | Pubmed ID: 20367572 Challenges of T Cell Therapies for Virus-associated Diseases After Hematopoietic Stem Cell Transplantation Expert Opinion on Biological Therapy. Mar, 2010 | Pubmed ID: 20132056 Derivation of Human T Lymphocytes from Cord Blood and Peripheral Blood with Antiviral and Antileukemic Specificity from a Single Culture As Protection Against Infection and Relapse After Stem Cell Transplantation Blood. Apr, 2010 | Pubmed ID: 20110422 Long-term Outcome of EBV-specific T-cell Infusions to Prevent or Treat EBV-related Lymphoproliferative Disease in Transplant Recipients Blood. Feb, 2010 | Pubmed ID: 19880495 Generation of Epstein-Barr Virus-specific Cytotoxic T Lymphocytes Resistant to the Immunosuppressive Drug Tacrolimus (FK506) Blood. Nov, 2009 | Pubmed ID: 19759356 Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2009 | Pubmed ID: 19752751 Genome-wide Mapping of PiggyBac Transposon Integrations in Primary Human T Cells Journal of Immunotherapy (Hagerstown, Md. : 1997). Oct, 2009 | Pubmed ID: 19752750 Cytotoxic T Lymphocyte Therapy with Donor T Cells Prevents and Treats Adenovirus and Epstein-Barr Virus Infections After Haploidentical and Matched Unrelated Stem Cell Transplantation Blood. Nov, 2009 | Pubmed ID: 19700662 Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host Molecular Therapy : the Journal of the American Society of Gene Therapy. Sep, 2009 | Pubmed ID: 19584818 Genetic Modification of T Cells with IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytes Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep, 2009 | Pubmed ID: 19561536 Immunotherapy for Osteosarcoma: Genetic Modification of T Cells Overcomes Low Levels of Tumor Antigen Expression Molecular Therapy : the Journal of the American Society of Gene Therapy. Oct, 2009 | Pubmed ID: 19532139 Functionally Active Virus-specific T Cells That Target CMV, Adenovirus, and EBV Can Be Expanded from Naive T-cell Populations in Cord Blood and Will Target a Range of Viral Epitopes Blood. Aug, 2009 | Pubmed ID: 19443656 T Lymphocytes Coexpressing CCR4 and a Chimeric Antigen Receptor Targeting CD30 Have Improved Homing and Antitumor Activity in a Hodgkin Tumor Model Blood. Jun, 2009 | Pubmed ID: 19377047 Genetic Manipulation of Tumor-specific Cytotoxic T Lymphocytes to Restore Responsiveness to IL-7 Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2009 | Pubmed ID: 19259067 Production Assistance for Cellular Therapies (PACT): Four-year Experience from the United States National Heart, Lung, and Blood Institute (NHLBI) Contract Research Program in Cell and Tissue Therapies Transfusion. Apr, 2009 | Pubmed ID: 19170985 Enhancing the in Vivo Expansion of Adoptively Transferred EBV-specific CTL with Lymphodepleting CD45 Monoclonal Antibodies in NPC Patients Blood. Mar, 2009 | Pubmed ID: 18971421 In Vivo Fluorescent Optical Imaging of Cytotoxic T Lymphocyte Migration Using IRDye800CW Near-infrared Dye Applied Optics. Nov, 2008 | Pubmed ID: 19122737 Virus-specific T Cells Engineered to Coexpress Tumor-specific Receptors: Persistence and Antitumor Activity in Individuals with Neuroblastoma Nature Medicine. Nov, 2008 | Pubmed ID: 18978797 Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy Journal of Immunotherapy (Hagerstown, Md. : 1997). Sep, 2008 | Pubmed ID: 18600178 Cytotoxic T Lymphocytes Directed to the Preferentially Expressed Antigen of Melanoma (PRAME) Target Chronic Myeloid Leukemia Blood. Sep, 2008 | Pubmed ID: 18591381 Antitumor Activity of EBV-specific T Lymphocytes Transduced with a Dominant Negative TGF-beta Receptor Journal of Immunotherapy (Hagerstown, Md. : 1997). Jun, 2008 | Pubmed ID: 18463534 An Inducible Caspase 9 Safety Switch Can Halt Cell Therapy-induced Autoimmune Disease Journal of Immunology (Baltimore, Md. : 1950). May, 2008 | Pubmed ID: 18424760 Using Dendritic Cell Maturation and IL-12 Producing Capacity As Markers of Function: a Cautionary Tale Journal of Immunotherapy (Hagerstown, Md. : 1997). May, 2008 | Pubmed ID: 18391760 Identification of Hexon-specific CD4 and CD8 T-cell Epitopes for Vaccine and Immunotherapy Journal of Virology. Jan, 2008 | Pubmed ID: 17942545 Gene-engineered Varicella-zoster Virus Reactive CD4+ Cytotoxic T Cells Exert Tumor-specific Effector Function Cancer Research. Sep, 2007 | Pubmed ID: 17804749 Inducible Caspase 9 Suicide Gene to Improve the Safety of Allodepleted T Cells After Haploidentical Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Aug, 2007 | Pubmed ID: 17640595 Co-expression of Cytokine and Suicide Genes to Enhance the Activity and Safety of Tumor-specific Cytotoxic T Lymphocytes Blood. Oct, 2007 | Pubmed ID: 17638856 What Influence Has B-cell Depletion on Viral Infections? Leukemia & Lymphoma. Jul, 2007 | Pubmed ID: 17613749 Complete Responses of Relapsed Lymphoma Following Genetic Modification of Tumor-antigen Presenting Cells and T-lymphocyte Transfer Blood. Oct, 2007 | Pubmed ID: 17609424 Autologous Designer Antigen-presenting Cells by Gene Modification of T Lymphocyte Blasts with IL-7 and IL-12 Journal of Immunotherapy (Hagerstown, Md. : 1997). Jul-Aug, 2007 | Pubmed ID: 17589291 Regression of Experimental Medulloblastoma Following Transfer of HER2-specific T Cells Cancer Research. Jun, 2007 | Pubmed ID: 17575166 Epstein Barr Virus Specific Cytotoxic T Lymphocytes Expressing the Anti-CD30zeta Artificial Chimeric T-cell Receptor for Immunotherapy of Hodgkin Disease Blood. Oct, 2007 | Pubmed ID: 17507664 Dendritic Cell Function After Gene Transfer with Adenovirus-calcium Phosphate Co-precipitates Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2007 | Pubmed ID: 17235318 Contact-activated Monocytes: Efficient Antigen Presenting Cells for the Stimulation of Antigen-specific T Cells Journal of Immunotherapy (Hagerstown, Md. : 1997). Jan, 2007 | Pubmed ID: 17198088 Improving T Cell Therapy for Cancer Annual Review of Immunology. 2007 | Pubmed ID: 17129181 Quantification of a Low Cellular Immune Response to Aid in Identification of Pediatric Liver Transplant Recipients at High-risk for EBV Infection Clinical Transplantation. Nov-Dec, 2006 | Pubmed ID: 17100717 Monoculture-derived T Lymphocytes Specific for Multiple Viruses Expand and Produce Clinically Relevant Effects in Immunocompromised Individuals Nature Medicine. Oct, 2006 | Pubmed ID: 16998485 T Lymphocytes Redirected Against the Kappa Light Chain of Human Immunoglobulin Efficiently Kill Mature B Lymphocyte-derived Malignant Cells Blood. Dec, 2006 | Pubmed ID: 16926291 Treatment of Solid Organ Transplant Recipients with Autologous Epstein Barr Virus-specific Cytotoxic T Lymphocytes (CTLs) Blood. Nov, 2006 | Pubmed ID: 16835376 Use of Cytokine Polymorphisms and Epstein-Barr Virus Viral Load to Predict Development of Post-transplant Lymphoproliferative Disorder in Paediatric Liver Transplant Recipients Clinical Transplantation. May-Jun, 2006 | Pubmed ID: 16824159 Adoptive Immunotherapy for Hodgkin's Lymphoma International Journal of Hematology. Jun, 2006 | Pubmed ID: 16787867 In Vivo Expansion of LMP 1- and 2-specific T-cells in a Patient Who Received Donor-derived EBV-specific T-cells After Allogeneic Stem Cell Transplantation Leukemia & Lymphoma. May, 2006 | Pubmed ID: 16753867 Assessing the Safety of Cytotoxic T Lymphocytes Transduced with a Dominant Negative Transforming Growth Factor-beta Receptor Journal of Immunotherapy (Hagerstown, Md. : 1997). May-Jun, 2006 | Pubmed ID: 16699368 Administration of Latent Membrane Protein 2-specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus-positive Lymphoma Clinical Lymphoma & Myeloma. Jan, 2006 | Pubmed ID: 16507214 Improving T Cell Therapy for Cancer Expert Opinion on Biological Therapy. Mar, 2006 | Pubmed ID: 16503732 Adenoviral Infections in Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2006 | Pubmed ID: 16503493 Target Antigen Expression on a Professional Antigen-presenting Cell Induces Superior Proliferative Antitumor T-cell Responses Via Chimeric T-cell Receptors Journal of Immunotherapy (Hagerstown, Md. : 1997). Jan-Feb, 2006 | Pubmed ID: 16365597 Hitchhiker's Guide to the T Cell Nature Medicine. Oct, 2005 | Pubmed ID: 16211037 Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-positive Nasopharyngeal Carcinoma and Lymphoma Journal of Immunology (Baltimore, Md. : 1950). Sep, 2005 | Pubmed ID: 16148164 Quantitative EBV Viral Loads and Immunosuppression Alterations Can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Sep, 2005 | Pubmed ID: 16095501 A Chimeric T Cell Antigen Receptor That Augments Cytokine Release and Supports Clonal Expansion of Primary Human T Cells Molecular Therapy : the Journal of the American Society of Gene Therapy. Nov, 2005 | Pubmed ID: 15979412 HLA Type-independent Generation of Antigen-specific T Cells for Adoptive Immunotherapy European Journal of Immunology. Jul, 2005 | Pubmed ID: 15915543 An Inducible Caspase 9 Safety Switch for T-cell Therapy Blood. Jun, 2005 | Pubmed ID: 15728125 Human Cytotoxic T Lymphocytes with Reduced Sensitivity to Fas-induced Apoptosis Blood. Jun, 2005 | Pubmed ID: 15713795 Cellular Immunity to Epstein-Barr Virus in Liver Transplant Recipients Treated with Rituximab for Post-transplant Lymphoproliferative Disease American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. Mar, 2005 | Pubmed ID: 15707412 Post-transplant Lymphoproliferative Disorders Annual Review of Medicine. 2005 | Pubmed ID: 15660500 Adenovirus As an Emerging Pathogen in Immunocompromised Patients British Journal of Haematology. Jan, 2005 | Pubmed ID: 15638847 Adoptive Immunotherapy for EBV-associated Malignancies Leukemia & Lymphoma. Jan, 2005 | Pubmed ID: 15621775 Treatment of Nasopharyngeal Carcinoma with Epstein-Barr Virus--specific T Lymphocytes Blood. Mar, 2005 | Pubmed ID: 15542583 Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease The Journal of Experimental Medicine. Dec, 2004 | Pubmed ID: 15611290 A Comparison of Gene Transfer and Antigen-loaded Dendritic Cells for the Generation of CD4+ and CD8+ Cytomegalovirus-specific T Cells in HLA-A2+ and HLA-A2- Donors Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Nov, 2004 | Pubmed ID: 15505607 Cellular Therapy of Epstein-Barr-virus-associated Post-transplant Lymphoproliferative Disease Best Practice & Research. Clinical Haematology. Sep, 2004 | Pubmed ID: 15498712 Treatment of Epstein-Barr Virus Lymphoproliferative Disease After Hematopoietic Stem-cell Transplantation with Hydroxyurea and Cytotoxic T-cell Lymphocytes Transplantation. Sep, 2004 | Pubmed ID: 15371682 Conserved CTL Epitopes on the Adenovirus Hexon Protein Expand Subgroup Cross-reactive and Subgroup-specific CD8+ T Cells Blood. Oct, 2004 | Pubmed ID: 15265797 The Generation and Characterization of LMP2-specific CTLs for Use As Adoptive Transfer from Patients with Relapsed EBV-positive Hodgkin Disease Journal of Immunotherapy (Hagerstown, Md. : 1997). Jul-Aug, 2004 | Pubmed ID: 15235393 Adoptive Immunotherapy for Posttransplantation Viral Infections Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. Mar, 2004 | Pubmed ID: 14993880 Evidence for the Presentation of Major Histocompatibility Complex Class I-restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes The Journal of Experimental Medicine. Feb, 2004 | Pubmed ID: 14769850 Prompt Versus Preemptive Intervention for EBV Lymphoproliferative Disease Blood. May, 2004 | Pubmed ID: 14751931 A Strategy for Treatment of Epstein-Barr Virus-positive Hodgkin's Disease by Targeting Interleukin 12 to the Tumor Environment Using Tumor Antigen-specific T Cells Cancer Gene Therapy. Feb, 2004 | Pubmed ID: 14685154 Fiber-modified Adenoviruses Generate Subgroup Cross-reactive, Adenovirus-specific Cytotoxic T Lymphocytes for Therapeutic Applications Blood. Feb, 2004 | Pubmed ID: 14525768 Adoptive T-cell Therapy for Epstein-Barr Virus-positive Hodgkin's Disease Acta Haematologica. 2003 | Pubmed ID: 14583675 Adoptive T-cell Therapy for EBV-associated Post-transplant Lymphoproliferative Disease Acta Haematologica. 2003 | Pubmed ID: 14583674 Human Telomerase Reverse Transcriptase-specific T-helper Responses Induced by Promiscuous Major Histocompatibility Complex Class II-restricted Epitopes Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2003 | Pubmed ID: 14581345 Induction of Antigen-specific Regulatory T Cells Following Overexpression of a Notch Ligand by Human B Lymphocytes Journal of Virology. Oct, 2003 | Pubmed ID: 14512537 Journal of Immunotherapy (Hagerstown, Md. : 1997). May-Jun, 2003 | Pubmed ID: 12806278 Identification of a Naturally Processed HLA-DR-restricted T-helper Epitope in Epstein-Barr Virus Nuclear Antigen Type 1 Journal of Immunotherapy (Hagerstown, Md. : 1997). May-Jun, 2003 | Pubmed ID: 12806275 Selective Depletion of Donor Alloreactive T Cells Without Loss of Antiviral or Antileukemic Responses Blood. Sep, 2003 | Pubmed ID: 12763937 The Dynamics of Herpesvirus and Polyomavirus Reactivation and Shedding in Healthy Adults: a 14-month Longitudinal Study The Journal of Infectious Diseases. May, 2003 | Pubmed ID: 12721937 Immunotherapy for Epstein-Barr Virus-associated Cancers in Children The Oncologist. 2003 | Pubmed ID: 12604735 New Insights into EBV-associated Post-transplant Lymphoproliferative Disease Lancet. Jan, 2003 | Pubmed ID: 12547538 Generating CTLs Against the Subdominant Epstein-Barr Virus LMP1 Antigen for the Adoptive Immunotherapy of EBV-associated Malignancies Blood. Mar, 2003 | Pubmed ID: 12411306 Identification of HLA-DP3-restricted Peptides from EBNA1 Recognized by CD4(+) T Cells Cancer Research. Dec, 2002 | Pubmed ID: 12499257 Autologous Epstein-Barr Virus (EBV)-specific Cytotoxic T Cells for the Treatment of Persistent Active EBV Infection Blood. Dec, 2002 | Pubmed ID: 12393655 Immunotherapy for Post-transplant Lymphoproliferative Disease British Journal of Haematology. Sep, 2002 | Pubmed ID: 12181039 Adapting a Transforming Growth Factor Beta-related Tumor Protection Strategy to Enhance Antitumor Immunity Blood. May, 2002 | Pubmed ID: 11964281 Epstein-Barr Virus-specific Human T Lymphocytes Expressing Antitumor Chimeric T-cell Receptors: Potential for Improved Immunotherapy Blood. Mar, 2002 | Pubmed ID: 11877273 Diagnosis and Treatment of Posttransplantation Lymphoproliferative Disease After Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation. 2002 | Pubmed ID: 11846351 Immunotherapy to Reconstitute Immunity to DNA Viruses Seminars in Hematology. Jan, 2002 | Pubmed ID: 11799528 Epstein-Barr Virus (EBV)-specific Cytotoxic T Lymphocytes for the Prevention and Treatment of EBV-associated Post-transplant Lymphomas Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer. 2002 | Pubmed ID: 11785836 Generation of EBV-specific CD4+ Cytotoxic T Cells from Virus Naive Individuals Journal of Immunology (Baltimore, Md. : 1950). Jan, 2002 | Pubmed ID: 11777989 שינוי מערכת Transposon piggyBac של תאי T אנושיים ראשוניים Sunandan Saha1,2, Yozo Nakazawa3, Leslie E. Huye4,5, Joseph E. Doherty2,6, Daniel L. Galvan2, Cliona M. Rooney4,5,7, Matthew H. Wilson1,2,4,8 1Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, 2Department of Medicine, Division of Nephrology, Baylor College of Medicine, 3Department of Immunology and Pathology, Shinshu University School of Medicine, 4Center for Cell and Gene Therapy, Baylor College of Medicine, 5Department of Pediatrics, Baylor College of Medicine, 6Program in Cell and Molecular Biology, Baylor College of Medicine, 7Department of Molecular Virology and Microbiology, Baylor College of Medicine, 8Michael E. DeBakey VA Medical Center JoVE 4235 Immunology and Infection דור Multivirus ספציפיים תאים T כדי למנוע / לטפל זיהומים נגיפיים לאחר השתלת allogeneic תא גזע hematopoietic Ulrike Gerdemann1, Juan F. Vera1, Cliona M. Rooney1, Ann M. Leen1 1Center for Cell and Gene Therapy, Baylor College of Medicine JoVE 2736 Immunology and Infection
שינוי מערכת Transposon piggyBac של תאי T אנושיים ראשוניים Sunandan Saha1,2, Yozo Nakazawa3, Leslie E. Huye4,5, Joseph E. Doherty2,6, Daniel L. Galvan2, Cliona M. Rooney4,5,7, Matthew H. Wilson1,2,4,8 1Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, 2Department of Medicine, Division of Nephrology, Baylor College of Medicine, 3Department of Immunology and Pathology, Shinshu University School of Medicine, 4Center for Cell and Gene Therapy, Baylor College of Medicine, 5Department of Pediatrics, Baylor College of Medicine, 6Program in Cell and Molecular Biology, Baylor College of Medicine, 7Department of Molecular Virology and Microbiology, Baylor College of Medicine, 8Michael E. DeBakey VA Medical Center JoVE 4235 Immunology and Infection
דור Multivirus ספציפיים תאים T כדי למנוע / לטפל זיהומים נגיפיים לאחר השתלת allogeneic תא גזע hematopoietic Ulrike Gerdemann1, Juan F. Vera1, Cliona M. Rooney1, Ann M. Leen1 1Center for Cell and Gene Therapy, Baylor College of Medicine JoVE 2736 Immunology and Infection